Clinical usefulness of admission versus monitoring troponin in patients with coronavirus disease 2019

Affiliations

• ¹ Innovative Therapies in Haemostasis, Inserm, Université Paris Cité, 75006 Paris, France; Emergency Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.
• ² Innovative Therapies in Haemostasis, Inserm, Université Paris Cité, 75006 Paris, France; Haematology Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.
• ³ Biochemistry Department, Georges Pompidou European Hospital, AP-HP, Université de Paris, 75015 Paris, France.
• ⁴ Emergency Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.
• ⁵ Vascular Medicine Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.
• ⁶ Innovative Therapies in Haemostasis, Inserm, Université Paris Cité, 75006 Paris, France; Respiratory Medicine Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.
• ⁷ Innovative Therapies in Haemostasis, Inserm, Université Paris Cité, 75006 Paris, France; Medical Intensive Care Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France.
• ⁸ Emergency Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France; Paris Cardiovascular Research Centre (PARCC), Inserm, UMR-S970, Université de Paris, 75015 Paris, France. Electronic address: richard.chocron@aphp.fr.